DK257988D0 - Nye peptider - Google Patents

Nye peptider

Info

Publication number
DK257988D0
DK257988D0 DK257988A DK257988A DK257988D0 DK 257988 D0 DK257988 D0 DK 257988D0 DK 257988 A DK257988 A DK 257988A DK 257988 A DK257988 A DK 257988A DK 257988 D0 DK257988 D0 DK 257988D0
Authority
DK
Denmark
Prior art keywords
new peptides
peptides
new
Prior art date
Application number
DK257988A
Other languages
English (en)
Inventor
Jens Joergen Veilgaard Brange
Svend Havelund
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK257988A priority Critical patent/DK257988D0/da
Publication of DK257988D0 publication Critical patent/DK257988D0/da
Priority to KR1019900700042A priority patent/KR900701840A/ko
Priority to DE89906057T priority patent/DE68912777T2/de
Priority to FI905566A priority patent/FI905566A0/fi
Priority to AU36928/89A priority patent/AU615760B2/en
Priority to AT89906057T priority patent/ATE100824T1/de
Priority to EP89906057A priority patent/EP0419504B1/en
Priority to PCT/DK1989/000117 priority patent/WO1989010937A1/en
Priority to HU893263A priority patent/HUT55442A/hu
Priority to ZA893508A priority patent/ZA893508B/xx
Priority to IE153689A priority patent/IE65504B1/en
Priority to NZ229108A priority patent/NZ229108A/en
Priority to DK265590A priority patent/DK265590A/da
Priority to NO90904841A priority patent/NO904841L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK257988A 1988-05-11 1988-05-11 Nye peptider DK257988D0 (da)

Priority Applications (14)

Application Number Priority Date Filing Date Title
DK257988A DK257988D0 (da) 1988-05-11 1988-05-11 Nye peptider
HU893263A HUT55442A (en) 1988-05-11 1989-05-10 Process for producing insuline analogues
EP89906057A EP0419504B1 (en) 1988-05-11 1989-05-10 Insulin analogues
DE89906057T DE68912777T2 (de) 1988-05-11 1989-05-10 Insulin-analoge.
FI905566A FI905566A0 (fi) 1988-05-11 1989-05-10 Insulin analoger.
AU36928/89A AU615760B2 (en) 1988-05-11 1989-05-10 Insulin analogues
AT89906057T ATE100824T1 (de) 1988-05-11 1989-05-10 Insulin-analoge.
KR1019900700042A KR900701840A (ko) 1988-05-11 1989-05-10 인슐린 유사체
PCT/DK1989/000117 WO1989010937A1 (en) 1988-05-11 1989-05-10 Insulin analogues
ZA893508A ZA893508B (en) 1988-05-11 1989-05-11 Insulin analogues
IE153689A IE65504B1 (en) 1988-05-11 1989-05-11 Insulin analogues
NZ229108A NZ229108A (en) 1988-05-11 1989-05-12 Insulin analogues and pharmaceutical compositions
DK265590A DK265590A (da) 1988-05-11 1990-11-06 Insulinanaloger
NO90904841A NO904841L (no) 1988-05-11 1990-11-07 Insulinanaloger.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK257988A DK257988D0 (da) 1988-05-11 1988-05-11 Nye peptider

Publications (1)

Publication Number Publication Date
DK257988D0 true DK257988D0 (da) 1988-05-11

Family

ID=8113334

Family Applications (1)

Application Number Title Priority Date Filing Date
DK257988A DK257988D0 (da) 1988-05-11 1988-05-11 Nye peptider

Country Status (10)

Country Link
EP (1) EP0419504B1 (da)
KR (1) KR900701840A (da)
AU (1) AU615760B2 (da)
DE (1) DE68912777T2 (da)
DK (1) DK257988D0 (da)
HU (1) HUT55442A (da)
IE (1) IE65504B1 (da)
NZ (1) NZ229108A (da)
WO (1) WO1989010937A1 (da)
ZA (1) ZA893508B (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641631B2 (en) * 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
DK155690D0 (da) * 1990-06-28 1990-06-28 Novo Nordisk As Nye peptider
DK10191D0 (da) * 1991-01-22 1991-01-22 Novo Nordisk As Hidtil ukendte peptider
DE19726167B4 (de) * 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DK1265630T3 (da) 2000-03-24 2006-10-09 Genentech Inc Anvendelse af insulin til behandling af brusksygdomme
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
MY146082A (en) 2005-09-14 2012-06-29 Sanofi Aventis Deutschland Cleavage of precursors of insulins by a variant of trypsin
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
BRPI0907119A2 (pt) 2008-01-09 2015-07-14 Sanofi Aventis Deutschland Derivados de insulina tendo um perfil de ação de tempo extremamente retardado
AU2009203809B2 (en) * 2008-01-09 2013-07-25 Sanofi-Aventis Deutschland Gmbh Novel insulin derivatives having an extremely delayed time-action profile
JP5762001B2 (ja) 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
DE102008051834A1 (de) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Kombination von einem Insulin und einem GLP-1-Agonisten
DE102009038210A1 (de) 2009-08-20 2011-03-03 Sanofi-Aventis Deutschland Gmbh Kombination von einem Insulin und einem GLP-1-Agonisten
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
DE102008053048A1 (de) 2008-10-24 2010-04-29 Sanofi-Aventis Deutschland Gmbh Kombination von einem Insulin und einem GLP-1-Agonisten
KR101853606B1 (ko) 2009-07-06 2018-05-03 사노피-아벤티스 도이칠란트 게엠베하 메티오닌을 함유하는 수성 인슐린 제제
JP5675799B2 (ja) * 2009-07-06 2015-02-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 遅効性インスリン製剤
TW201105346A (en) * 2009-07-06 2011-02-16 Sanofi Aventis Deutschland Heat-stable and vibration-stable insulin preparations
SG178195A1 (en) 2009-07-31 2012-03-29 Sanofi Aventis Deutschland Long acting insulin composition
SG178193A1 (en) 2009-07-31 2012-03-29 Sanofi Aventis Deutschland Prodrugs comprising an insulin linker conjugate
KR101337322B1 (ko) 2009-11-13 2013-12-06 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
DK2498802T3 (da) 2009-11-13 2015-04-13 Sanofi Aventis Deutschland Farmaceutisk præparat omfattende en glp-1-agonist, et insulin og en methionin
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
EP2438930A1 (en) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrugs comprising an exendin linker conjugate
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
PL2750699T3 (pl) 2011-08-29 2015-12-31 Sanofi Aventis Deutschland Kombinacja farmaceutyczna do stosowania w kontroli glikemii u pacjentów z cukrzycą typu 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
RU2014127270A (ru) 2011-12-15 2016-02-10 Шанхай Хэнжуй Фармасьютикал Ко., Лтд. Аналог человеческого инсулина и его ацилированное производное
WO2013173923A1 (en) 2012-05-25 2013-11-28 Diamedica, Inc. Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
PT2854841T (pt) 2012-06-04 2017-05-15 Diamedica Inc Isoformas de glicosilação da calicreína 1 em tecido humano
MX360420B (es) 2012-12-19 2018-10-31 Wockhardt Ltd Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
TWI641381B (zh) 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
AU2014326181A1 (en) 2013-09-30 2016-03-17 Wockhardt Limited Pharmaceutical composition
AU2014333979B2 (en) 2013-10-07 2018-02-15 Novo Nordisk A/S Novel derivative of an insulin analogue
CN112957455A (zh) 2014-01-09 2021-06-15 赛诺菲 胰岛素类似物和/或胰岛素衍生物的稳定化药物制剂
EP3091965A1 (en) 2014-01-09 2016-11-16 Sanofi Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
SG11201604706TA (en) 2014-01-09 2016-07-28 Sanofi Sa Stabilized pharmaceutical formulations of insulin aspart
WO2016001862A1 (en) 2014-07-04 2016-01-07 Wockhardt Limited Extended release formulations of insulins
AU2015359376B2 (en) 2014-12-12 2021-09-09 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3260548A1 (en) 2016-06-21 2017-12-27 Enzypep B.V. Enzymatic coupling of (oligo)peptides to the b-chain of an insulin receptor ligand
ES2886837T3 (es) 2016-12-16 2021-12-21 Novo Nordisk As Composiciones farmacéuticas que contienen insulina
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2536040A1 (de) * 1975-08-13 1977-02-24 Hoechst Ag Insulin-analoga mit biologischer wirkung
NZ187300A (en) * 1977-05-27 1982-08-17 Univ California Dna transfer vector and micro-organism modified to contain a nucleotide sequence equivalent to the gene of a higher organism
US4343898A (en) * 1980-02-11 1982-08-10 Novo Industri A/S Process for preparing esters of human insulin
DE3880346T2 (de) * 1987-02-25 1993-07-29 Novonordisk As Insulinderivate.

Also Published As

Publication number Publication date
AU3692889A (en) 1989-11-29
IE891536L (en) 1989-11-11
WO1989010937A1 (en) 1989-11-16
DE68912777D1 (de) 1994-03-10
ZA893508B (en) 1990-01-31
AU615760B2 (en) 1991-10-10
HU893263D0 (en) 1991-03-28
NZ229108A (en) 1992-05-26
IE65504B1 (en) 1995-11-01
EP0419504A1 (en) 1991-04-03
HUT55442A (en) 1991-05-28
KR900701840A (ko) 1990-12-04
DE68912777T2 (de) 1994-05-11
EP0419504B1 (en) 1994-01-26

Similar Documents

Publication Publication Date Title
DK155690D0 (da) Nye peptider
NO894919D0 (no) Nye aminobenzoater.
DK612689A (da) Peptidderivater
NO874159L (no) Nye lymfokin-relaterte peptider.
DK163689D0 (da) Peptidderivater
DK666589A (da) D-vitamin homologer
DK111489D0 (da) Peptider
NO952650D0 (no) Nye peptider
DK197989A (da) Peptidanaloger
FI905741A7 (fi) Peptidit
DK158390D0 (da) Nye peptider
DK616889A (da) Nye alfa-cyano-beta-oxopropionamider
DK355189D0 (da) Nye proteiner
KR900700503A (ko) 펩티드
DK177789A (da) Peptidderivater
FI905453A7 (fi) Prokalsitoniinipeptidejä
DK312488D0 (da) Nye peptider
DK344887D0 (da) Nye peptider
DK344987D0 (da) Nye peptider
NO912122L (no) Nye allylaminoetylazoler.
DK171489D0 (da) Peptidderivater
DK611387D0 (da) Nye peptidderivater
NO921024D0 (no) Nye lymfokin-relaterte peptider
DK51188D0 (da) Peptider
DK595689A (da) Peptider

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment